Evidence map›Paper›PMID 41445599›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Bivariate GSA-MiXeR: A Novel Tool for Functional Genomic Analyses Implicates Diverse Neural Cell Types for Psychiatric and Neurodegenerative Disorders.

Nadine Parker, Julian Furher, Dat Nguyen, Vera Fominykh, Piotr Jaholkowski, Ibrahim Akkouh, Kevin S O'Connell, Espen Hagen, Shahram Bahrahmi, Dag Årsland and 21 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Nadine ParkerCentre for Precision Psychiatry, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-8369-0152
Julian FurherCentre for Precision Psychiatry, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.
Dat NguyenCentre for Precision Psychiatry, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.
Vera FominykhCentre for Precision Psychiatry, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.
Piotr JaholkowskiCentre for Precision Psychiatry, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.
Ibrahim AkkouhCentre for Precision Psychiatry, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.
Kevin S O'ConnellCentre for Precision Psychiatry, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.
Espen HagenCentre for Precision Psychiatry, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.
Shahram BahrahmiCentre for Precision Psychiatry, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.
Dag ÅrslandCentre for Age-Related Medicine, Stavanger University Hospital, Stavanger Norway. Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London UK.
Sverre BerghResearch Centre for Age-related Functional Decline and Disease, Innlandet Hospital Trust, Ottestad, Norway.
Torgeir EngstadUniversity Hospital of North Norway HF, Tromsø, Norway.
Tormod FladbyDepartment of Neurology, Akershus University Hospital, Lørenskog Norway. Institute of Clinical Medicine, University of Oslo, Oslo Norway.
Anne-Brita KnapskogDepartment of Geriatric Medicine, Oslo University Hospital, Oslo, Norway.
Karin PerssonNorwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway, Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Gøril Rolfseng GrøntvedtDepartment of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Bengt-Ove MadsenDepartment of Geriatric and Internal Medicine, Sørlandet Hospital, Arendal, Norway.
Arvid RongveDepartment of Research and Innovation, Helse Fonna, Haugesund, Norway.
Ingvild SaltvedtDepartment of Geriatrics, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.
Sigrid B SandoDepartment of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Katja SchefflerDepartment of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Geir SelbækNorwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway, Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Eystein StordalDepartment of Psychiatry, Namsos Hospital, Namsos, Norway.
Mathias ToftDepartment of Neurology, Oslo University Hospital, Oslo, Norway.
Leiv Otto WatneOslo Delirium Research Group, Department of Geriatric Medicine, Akershus University Hospital, Lørenskog, Norway.
Srdjan DjurovicDepartment of Medical Genetics, Oslo University Hospital, Oslo, Norway.
Olav B SmelandCentre for Precision Psychiatry, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.
Anders M DaleJ. Craig Venter Institute, San Diego, CA, USA.
Alexey A ShadrinCentre for Precision Psychiatry, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.
Ole A AndreassenCentre for Precision Psychiatry, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.
Oleksandr FreiCentre for Precision Psychiatry, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.

Funding

OTA-21-015A Post-Acute Sequelae of SARS-CoV-2 Infection Initiative: NYU Langone Health Clinical Science Core, Data Resource Core, and PASC Biorepository CoreOT2HL161847 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GROSS, RACHEL SHARON, HORWITZ, LEORA · 2021 to 2025
$651.0M
ABCD-USA Consortium: Data Analysis, Informatics and Resource CenterU24DA041123 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ANDERS M DALE · 2015 to 2026
$51.5M
Healthy Brain and Child Development National Consortium Data Coordinating CenterU24DA055330 · NIDA · WASHINGTON UNIVERSITY · PI ANDERS M DALE, Damien A Fair · 2021 to 2026
$34.6M
The VETSA Longitudinal MRI Twin Study of Aging (VETSA MRI 4)R01AG076838 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ANDERS M DALE, Jeremy A Elman · 2022 to 2026
$8.7M
3/7 Psychiatric Genomics Consortium: Advancing Discovery and ImpactR01MH124839 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ANDREASSEN, OLE A, HUCKINS, LAURA MARIANNE · 2021 to 2025
$2.0M
NHLBI NIH HHS OT2 HL161847NIA NIH HHS R01 AG076838NIDA NIH HHS U24 DA041123NIDA NIH HHS U24 DA055330NIMH NIH HHS R01 MH124839
6 · The paper itself

Abstract

The growing number of genomic discoveries in complex human traits has highlighted the need for advanced functional genomics tools that parse their polygenic and pleiotropic genetic architecture to provide biological insights. We present bivariate GSA-MiXeR, a novel tool that models the partitioned heritability and covariance of two traits within a genomic region of interest (ROI) and estimates the (i) trait-specific fold enrichment, (ii) local genetic correlation, and (iii) local genetic omnibus statistic for ranking genomic ROIs. Unlike previous methods, our tool estimates local genetic correlations both in continuous and disjoint genomic ROIs, expanding the ability to assess local genetic overlap among complex traits. We perform simulations to validate our tool and illustrate its utility in applied analyses that implicate diverse neural cell types for psychiatric and neurodegenerative disorders using single cell RNA sequencing data. Bivariate GSA-MiXeR provides new analytical avenues that facilitate a transition from genetic discovery to mechanistic insights.

Identifiers

PMID41445599
PMCPMC12723773

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.